A screening program for gestational diabetes mellitus (GDM) is being evaluated in a cohort of 500 pregnant women from Mumbai. A fasting blood glucose (FBG) test is compared against the oral glucose tolerance test (OGTT), which is the gold standard. The results are: - True positives: 72 - False positives: 48 - True negatives: 360 - False negatives: 20 A clinician interprets a negative FBG test as reassuring and discharges the patient without further testing. Based on the diagnostic accuracy of this test, which statement best reflects the clinical implication of this interpretation?

Explanation

## Sensitivity, Specificity, and Clinical Decision-Making in GDM Screening ### Calculation of Test Metrics **Key Point:** Before interpreting a negative test, we must calculate sensitivity—the ability of the test to detect disease when it is truly present. #### Sensitivity Calculation $$\text{Sensitivity} = \frac{\text{TP}}{\text{TP + FN}} = \frac{72}{72 + 20} = \frac{72}{92} = 0.783 = 78.3\%$$ #### Specificity Calculation $$\text{Specificity} = \frac{\text{TN}}{\text{TN + FP}} = \frac{360}{360 + 48} = \frac{360}{408} = 0.882 = 88.2\%$$ ### Clinical Interpretation of Low Sensitivity **High-Yield:** A sensitivity of 78.3% means that the FBG test misses approximately **21.7% of women who truly have GDM** (false negatives = 20 out of 92 with disease). This is NOT adequate for a screening test in a high-risk population. **Clinical Pearl:** In obstetrics, missing GDM carries significant maternal and fetal morbidity (preeclampsia, macrosomia, neonatal hypoglycemia). A negative screening test with 78% sensitivity is insufficient to rule out disease—further testing (OGTT, repeat FBG, or HbA1c) is mandatory. ### SnOUT and SpIN Mnemonics **Mnemonic:** - **SnOUT** = **Sn**sitive test, **N**egative result rules **OUT** disease. Use high-sensitivity tests to exclude disease. - **SpIN** = **Sp**ecific test, **P**ositive result rules **IN** disease. Use high-specificity tests to confirm disease. In this case: - Sensitivity 78.3% is **NOT high enough** to rule out GDM with a negative result. - Specificity 88.2% is reasonably high, so a positive FBG may help confirm GDM. ### Why This Test Fails as a Screening Tool | Metric | Value | Interpretation | |--------|-------|----------------| | Sensitivity | 78.3% | Misses 1 in 5 true cases → **Inadequate for screening** | | Specificity | 88.2% | Correctly identifies 88% without disease → Acceptable | | **Clinical implication** | — | A negative test does NOT exclude GDM; further testing needed | **Warning:** Discharging a patient based on a single negative FBG in GDM screening is a common error. The low sensitivity means the test is not sensitive enough to safely exclude the condition.